It's not surprising that the most important drug candidates and targets
are o en super challenging when it comes to affinity screening.
Immobilization-dependent SPR, and sample-consuming ITC really
struggle with affinity screening campaigns for applications involving
PROTAC binary and ternary complexes, fragment libraries, and
intrinsically disordered proteins.
These are precisely the applications where Dianthus excels.
